Evaluation of a formula with low protein content and supplemented with probiotic agents after breast milk weaning;Évaluation d'une préparation pour nourrissons à teneur réduite en protéines et enrichie en probiotiques, en relais de l'allaitement maternel

Archives de Pediatrie

Volumn 13, Issue 10, 2006, Pages 1309-1315

  Huet, F ^a   Lachambre, E ^b   Beck, L ^b   Van Egroo, L D ^b   Sznajder, M ^c  

^a Medical University of Dijon   (France)

^b Nestlé France ^*  (France)

^c HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Growth; Infant formula; Probiotics

Indexed keywords

PROBIOTIC AGENT;

ARTICLE; ARTIFICIAL MILK; BIFIDOBACTERIUM ANIMALIS; BODY GROWTH; BODY HEIGHT; BODY SIZE; BREAST MILK; CHILD GROWTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEAD CIRCUMFERENCE; HUMAN; INFANCY; INFANT; LIFE CYCLE; MULTICENTER STUDY; NORMAL HUMAN; PEDIATRICIAN; PRESCRIPTION; PROTEIN CONTENT; PROTEIN RESTRICTION; SUPPLEMENTATION; WEANING; WEIGHT GAIN; BIFIDOBACTERIUM; CHEMISTRY; COHORT ANALYSIS; COMPARATIVE STUDY; GROWTH, DEVELOPMENT AND AGING; NEWBORN; PROTEIN INTAKE;

BIFIDOBACTERIUM; COHORT STUDIES; DIETARY PROTEINS; HUMANS; INFANT FORMULA; INFANT, NEWBORN; PROBIOTICS; WEANING;

EID: 33749126982     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2006.06.025     Document Type: Article

References (30)

1. Allaitement maternel - Mise en œuvre et poursuite dans les 6 premiers mois de vie de l'enfant. Rapport et Recommandations pour la pratique clinique de l'Anaes - Mai 2002.
2. Howie P.W., Forsyth J.S., Ogston S.A., et al. Protective effect of breast feeding against infection. BMJ 300 (1990) 11-16
3. Guilley N., Roumilhac M., Joriot S., et al. L'allaitement maternel : bénéfices et limites. Ann. Pediatr. (Paris) 46 (1999) 785-798
4. Arrêté du 1er juillet 1976 modifié par les arrêtés des 05.01.81, 04.08.86, 11.01.94, 17.04.98, 18.05.99 et 05.10.2000 relatif aux aliments destinés aux nourrissons et enfants en bas âge.
5. Directive de la Commission du 14 mai 1991 (91/321/CEE) modifiée par l'Acte d'adhésion du 24.06.94 et les directives 96/4/CEE et 1999/50 CEE concernant les préparations pour nourrissons et les préparations de suite.
6. Saavedra J.M. Clinical applications of probiotic agents. Am. J. Clin. Nutr. 73 suppl (2001) 1147S-1151S
7. Rochat F. Effets biologiques des modificateurs de la flore intestinale. Arch. Pediatr. 11 (2004) 576-577
8. Mountzouris K.C., McCartney A.L., and Gibson G.R. Intestinal microflora of human infants and current trends for its nutritional modulation. Br. J. Nutr. 87 (2002) 405-420
9. Chouraqui J.P., Van Egroo L.D., and Fichot M.C. Acidified milk formula supplemented with Bifidobacterium lactis: impact of infant diarrhea in residential care settings. JPGN 38 (2004) 288-292
10. Saavedra J.M., Bauman N.A., Oung I., et al. Feeding of bifidobacterium bifidum and streptococcus thermophilus to infants in hospital for prevention of diarrhea and shedding of rotavirus. Lancet 344 (1994) 1046-1049
11. Isolauri E., Arvola T., Sütas Y., et al. Probiotics in the management of atopic eczema. Clin. Exp. Allergy 30 (2000) 1604-1610
12. Saavedra J.M., Abi-Hanna A., Moore N., et al. Long-term consumption of infant formulas containing live probiotic bacteria: tolerance and safety. Am. J. Clin. Nutr. 79 (2004) 261-267
13. Comité de nutrition de la société française de pédiatrie. Besoins en protéines des nourrissons et enfants en bonne santé. Arch. Pediatr. 4 (1997) 373-382
14. Joint FAO/WHO Expert Consultation on Diet. Nutrition and the Prevention of Chronic Disease. Draft 26 April (2002), World Health Organization, Geneva
15. Rolland-Cachera M.F., Deheeger M., Akrout M., et al. Influence of macronutrients on adiposity development: a follow up study of nutrition and growth from 10 months to 8 years of age. Int. J. Obes. Relat. Metab. Disord. 19 (1995) 573-578
16. Gunnarsdottir I., and Thorsdottir I. Relationship between growth and feeding in infancy and body mass index at the age of 6 years. Int. J. Obes. Relat. Metab. Disord. 27 (2003) 1523-1527
17. Hoppe C., Molgaard C., Thomsen B.L., et al. Protein intake at 9 mo of age is associated with body size but not with body fat in 10-y-old Danish children. Am. J. Clin. Nutr. 79 (2004) 494-501
18. Aggett P.J., Agostini C., Goulet O., et al. The nutritional and safety assessment of breast milk substitutes and other dietary products for infants: a commentary by the ESPGHAN Committee on Nutrition. J. Pediatr. Gastroenterol. Nutr. 32 (2001) 256-258
19. Haschke F., van't Hof M.A., and and the Euro-Growth Study Group. Euro-Growth References for length, weight and body circumferences. J. Pediatr. Gastroenterol. Nutr. 31 Suppl 1 (2000) S14-S38
20. Schmidt I.M., Damgaard I.N., Boisen K.A., et al. Increased kidney growth in formula-fed versus breast-fed healthy infants. Pediatr. Nephrol. 19 (2004) 1137-1144
21. Bouby N., Trinh-Trang-Tan M.M., Laouari D., et al. Role of the urinary concentrating process in the renal effects of high protein intake. Kidney Int. 34 (1988) 4-12
22. Frelut M.L., Mariani Kurdidjan P., Boissinot C., et al. Impact d'une formule lactée acidifiée enrichie en bifidobactéries vivantes sur la flore intestinale et la croissance d'enfants de 0 à 3 mois. Arch. Pediatr. 6 suppl 2 (1999) 556s
23. Fukushima Y., Kawata Y., Hara H., et al. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int. J. Food Microbiol. 42 (1998) 39-44
24. Mack D.R., Michail S., Wei S., et al. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. 276 (1999) G941-G950
25. Teitelbaum J.E. Probiotics and the treatment of infectious diarrhea. Pediatr. Infect. Dis. J. 24 (2005) 267-268
26. Pletincx M., Legein J., and Vandenplas Y. Fungemia with Saccharomyces boulardii in a 1-year-old girl with protracted diarrhea. J. Pediatr. Gastroenterol. Nutr. 21 (1995) 113-115
27. Hennequin C., Kauffmann-Lacroix C., Jobert A., et al. Possible role of catheters in Saccharomyces boulardii fungemia. Eur. J. Clin. Microbiol. Infect. Dis. 19 (2000) 16-20
28. Riquelme A.J., Calvo M.A., Guzman A.M., et al. Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients. J. Clin. Gastroenterol. 36 (2003) 41-43
29. Borriello S.P., Hammes W.P., Holzapfel W., et al. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin. Infect. Dis. 36 (2003) 775-780
30. Afssa. Rapport du groupe de travail « alimentation infantile et modification de la flore intestinale » (Juin 2003)